Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase 2 1

Status

Completed 4Terminated 1

Sponsor Class

NIH 3INDUSTRY 2

Study Type

Interventional 5

Sponsor

Cancer Type

Lymphoid 668Other hematologic neoplasm 285CNS 115Sarcoma 92Other solid neoplasm 27Plasma cell 24Genitourinary 19Myeloid 12Dermatologic 11Gastrointestinal 8Thoracic 5Gynecologic 5Tumor-Agnostic 4Classical hematology 2Other neoplasm 1Other 1Head & Neck 1Endocrine 1Breast 1

Conditions

Lung Neoplasms 3Small Cell Lung Carcinoma 2Mesothelioma, Malignant 1

Interventions

Carboplatin 1167Cisplatin 889Pemetrexed 845pembrolizumab 622Paclitaxel 608Docetaxel 539Gemcitabine 428Radiotherapy 390Erlotinib Hydrochloride 381Nivolumab 344Bevacizumab 337Etoposide 296durvalumab 264Drug Therapy 260osimertinib 236atezolizumab 224Radiosurgery 194Gefitinib 186Vinorelbine 149Magnetic Resonance Spectroscopy 131Ipilimumab 129130-nm albumin-bound paclitaxel 124Cetuximab 113Blood Specimen Collection 106anlotinib 105tislelizumab 103Topotecan 103Specimen Handling 102Surgical Procedures, Operative 101Cyclophosphamide 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Vincristine × Thoracic × Clear all
NCT02566993 2021-10-28

ATLANTIS

PharmaMar

Phase 3 Completed
613 enrolled 46 charts
Thoracic

Small Cell Lung Carcinoma

NCT00002822 2013-12-19

Combination Chemotherapy Followed by Radiation Therapy in Patients With Small Cell Lung Cancer

National Cancer Institute (NCI)

Phase 3 Completed
400 enrolled
Thoracic

Lung Neoplasms

NCT00003364 2013-12-19

Radiation Therapy Plus Combination Chemotherapy In Treating Patients With Limited Stage Small Cell Lung Cancer

National Cancer Institute (NCI)

Phase 3 Completed
398 enrolled
Thoracic

Lung Neoplasms

NCT00003847 2013-09-05

VX-710, Doxorubicin, and Vincristine for the Treatment of Patients With Recurrent Small Cell Lung Cancer

Vertex Pharmaceuticals Incorporated

Phase 2 Terminated
36 enrolled
Thoracic

Lung Neoplasms, Small Cell Lung Carcinoma

NCT00075699 2013-08-07

Active Symptom Control With or Without Chemotherapy in Treating Patients With Malignant Pleural Mesothelioma

National Cancer Institute (NCI)

Phase 3 Completed
840 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡